BioChemics is a pharmaceutical company that has developed a portfolio of novel topical and transdermal drug delivery systems that allow a substantial amount of drugs that were previously undeliverable transdermally to be delivered through the skin. This new BSM technology joins BioChemics' established Derma-Release® technology, VALE (Vaso Active Lipid Encapsulated), and Mnet (Micro-needle Enabling Technology) clearly distinguishing the Company as one of most advanced drug delivery developers in the world. The Company has a significant portfolio of products under development as well as a number of strategic collaborations.
View Top Employees from BioChemics Inc| Website | http://biochemics.com |
| Revenue | $8.6 million |
| Employees | 4 (3 on RocketReach) |
| Founded | 1989 |
| Address | 99 Rosewood Dr Ste 270, Danvers, Massachusetts 01923, US |
| Phone | (978) 750-0090 |
| Fax | (978) 750-0085 |
| Technologies | |
| Industry | Biotechnology Research, Manufacturing General, Fitness, Drug Delivery, Manufacturing, Sports, Biotechnology, Health Care |
| SIC | SIC Code 283 Companies, SIC Code 2834 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular BioChemics Inc employee's phone or email?
BioChemics Inc Questions
The BioChemics Inc annual revenue was $8.6 million in 2024.
Marshall Sterman is the Chief Executive Officer and Chairman of BioChemics Inc.
3 people are employed at BioChemics Inc.
BioChemics Inc is based in Danvers, Massachusetts.
The NAICS codes for BioChemics Inc are [32, 3254, 32541, 325].
The SIC codes for BioChemics Inc are [283, 2834, 28].
Top BioChemics Inc Employees
-
35
-
ViewMaria Gnarra
Dermatology Advisory Consultant at BioChemics Inc
New York, New York, United States -
25+
Related Companies
